Annovis Bio Files Current Report
Ticker: ANVS · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1477845
| Field | Detail |
|---|---|
| Company | Annovis Bio, Inc. (ANVS) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: current-report, sec-filing
TL;DR
Annovis Bio filed an 8-K, check for updates.
AI Summary
Annovis Bio, Inc. filed an 8-K on June 20, 2025, reporting an event on June 19, 2025. The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. No specific financial details or material events were disclosed in the provided excerpt.
Why It Matters
This 8-K filing indicates Annovis Bio, Inc. is providing an update to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific financial or operational details that would indicate high risk.
Key Players & Entities
- Annovis Bio, Inc. (company) — Registrant
- June 19, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- Malvern, PA (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing by Annovis Bio, Inc.?
The purpose of this 8-K filing is to serve as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the earliest event date reported in this filing?
The earliest event date reported in this filing is June 19, 2025.
On what date was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on June 20, 2025.
In which state is Annovis Bio, Inc. incorporated?
Annovis Bio, Inc. is incorporated in Delaware.
What is the principal executive office address for Annovis Bio, Inc.?
The principal executive office address for Annovis Bio, Inc. is 101 Lindenwood Drive, Suite 225, Malvern, PA 19355.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Annovis Bio, Inc. (ANVS).